Evidence map›Paper›PMID 19158234›Full record

ArticleJournal of molecular endocrinology2009

Role of angiotensin II-induced rapid response genes in the regulation of enzymes needed for aldosterone synthesis.

Edson F Nogueira, Yewei Xing, Claudia A V Morris, William E Rainey

Open access · bronzeAbstract read
In one paragraph

Article in Journal of molecular endocrinology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 68 citations in OpenAlex.

  1. Renalase stimulates aldosterone production via PMCA4b/cAMP in NCI-H295R cells.Journal of enzyme inhibition and medicinal chemistry · 2026
    Article
  2. Article
  3. Diabetic nephropathy: Role of nitric oxide.Nitric oxide : biology and chemistry · 2025
    Review
  4. Review
  5. Article
  6. Review
  7. Steroidogenic Factor 1 (NR5A1) Activates ATF3 Transcriptional Activity.International journal of molecular sciences · 2020
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Signaling Interactions in the Adrenal Cortex.Frontiers in endocrinology · 2016
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Edson F NogueiraDepartment of Physiology, Medical College of Georgia, Augusta, Georgia 30912, USA.
Yewei Xing
Claudia A V Morris
William E Rainey
Augusta University · US

Funding

MECHANISMS LEADING TO ADRENAL ZONATIONR01DK043140 · NIDDK · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI William E Rainey · 1999 to 2026
$7.2M
MECHANISMS LEADING TO ADRENAL ZONATIONR29DK043140 · NIDDK · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI RAINEY, WILLIAM E · 1994 to 1998
–
NIDDK NIH HHS DK43140NIDDK NIH HHS R01 DK043140
6 · The paper itself

Abstract

Aldosterone is principally synthesized in the zona glomerulosa of the adrenal by a series of enzymatic reactions leading to the conversion of cholesterol to aldosterone. Angiotensin II (Ang II) is the major physiological regulator of aldosterone production acting acutely to stimulate aldosterone biosynthesis and chronically to increase the capacity of the adrenals to produce aldosterone. We previously defined eight transcription factors that are rapidly induced following Ang II treatment using three in vitro adrenocortical cell models. Herein, we investigated the function of these transcription factors in the regulation of the enzymes needed for aldosterone production. H295R adrenal cells were co-transfected with expression vectors for each transcription factor and promoter/reporter constructs prepared for genes encoding the enzymes needed for aldosterone production. NGFI-B family members induced promoter activity of 3-beta-hydroxysteroid-dehydrogenase type 2 (HSD3B2), 21-hydroxylase (CYP21A2), and aldosterone synthase (CYP11B2). The importance of NGFI-B in the regulation of CYP11B2 was also demonstrated by reduced CYP11B2 transcription in the presence of a dominant-negative-NGFI-B. A pharmacological approach was used to characterize the Ang II pathways regulating transcription of NGFI-B family genes. Transcription of NGFI-B members were decreased following inhibition of Ang II type 1 receptor (AT1R), protein kinase C (PKC), calcium/calmodulin-dependent kinases (CaMK), and Src tyrosine kinase (SRC). Taken together, these results suggest that Ang II binding to the AT1R increases activity of PKC, CaMK, and SRC, which act to increase expression of the family of NGFI-B genes as well as CYP11B2. Ang II induction of the NGFI-B family members represents an important pathway to increase the capacity of adrenal cells to produce aldosterone.

Indexed as

AldosteroneAngiotensin IICell Line, TumorCycloheximideCytochrome P-450 CYP11B2DNA-Binding ProteinsGene Expression Regulation, EnzymologicHumansModels, BiologicalNuclear Receptor Subfamily 4, Group A, Member 1Oligonucleotide Array Sequence AnalysisProgesterone ReductasePromoter Regions, GeneticReceptors, SteroidSignal TransductionSteroid 21-Hydroxylase3 beta-hydroxysteroid dehydrogenase type IIAldosteroneAngiotensin IICycloheximideCytochrome P-450 CYP11B2DNA-Binding ProteinsNR4A1 protein, humanNuclear Receptor Subfamily 4, Group A, Member 1Progesterone ReductaseReceptors, SteroidSteroid 21-HydroxylaseTranscription Factors

Identifiers

PMID19158234
PMCPMC4176876
OpenAlexW2165081445

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.